Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visilizumab in severe ulcerative colitis
NCT00267306Phase 2Completed
- Sponsor
- Facet Biotech Corporation
- Start
- Jan 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iron sucrose in ulcerative colitis (UC), sponsored by Facet Biotech Corporation. Started Jan 2004; status: completed.
02
Drugs
iron sucrose
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00267306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267306.